VAERS Explorer
Back to explore

Report #2857693

Received Sep 9, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
84 yrs
State
—
Recovered
Unknown
Vaccinated
Jan 1, 2021
Onset
Jan 13, 2021
Days to onset
12
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
COVID19COVID19 (COVID19 (MODERNA))MODERNA5025L20A—

Symptoms (3)

ImmunodeficiencyInappropriate schedule of product administrationWhite blood cell count

Symptom narrative

unsure if his low immune system was pre-existing since they just started checking it a year ago; Patient received first dose on 01-Jan-2021 and second dose on 13-Jan-2021; This spontaneous case was reported by a consumer and describes the occurrence of IMMUNODEFICIENCY (unsure if his low immune system was pre-existing since they just started checking it a year ago) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025L20A, 025L20A, 024M20A, 041B21A and 007J21-2A) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Chronic leukemia and Breathing difficult. On 01-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 13-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On 10-Feb-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On 27-Sep-2021, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On 07-Feb-2022, received fifth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On 13-Jan-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received first dose on 01-Jan-2021 and second dose on 13-Jan-2021). On an unknown date, the patient experienced IMMUNODEFICIENCY (unsure if his low immune system was pre-existing since they just started checking it a year ago) (seriousness criterion medically significant). At the time of the report, IMMUNODEFICIENCY (unsure if his low immune system was pre-existing since they just started checking it a year ago) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received first dose on 01-Jan-2021 and second dose on 13-Jan-2021) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, White blood cell count: white count being so high (over 100,000) for 20 years. No concomitant medication was reported. The patient received every Moderna vaccine that had come out since it was all started and the last one, he had was on Sep-2024. The patient's doctor told him that he needed to get another COVID vaccine this year. His health problems - breathing problems and chronic leukemia were pre-existing before receiving the COVID vaccines but was unsure if his low immune system was pre-existing or not since they just started checking it a year ago. The patient needed infusions to bring his hemoglobin and IgG back up after every 3 months. Most of the patient's problems were on account of his chronic leukemia and his white count being so high (over 100,000) for 20 years. The patient never had any ill effects from any of his vaccines. This case was linked to MOD-2025-789067, MOD-2025-789069, MOD-2025-789070 (Patient Link).; Reporter's Comments: Advanced age and Concurrent medical condition Chronic leukemia are confounders for the event immunodeficiency. The benefit -risk relationship of product is not affected by this report.

Current illness

Breathing difficult; Chronic leukemia

Lab data

Test Name: white count; Result Unstructured Data: white count being so high (over 100,000) for 20 years